• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Copley Scientific banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

People

Nanopharm appoints Mark Clement as Chairman of the Board

OINDP developer Nanopharm has announced the appointment of Mark Clement as non-executive Chairman of the Board. Clement has more than 25 years of experience in life sciences and is currently non-executive chairman or director of 6 companies in the industry. Nanopharm co-Founder and Director Rob Price said, "Mark’s extensive experience in managing Life Science … [Read more...] about Nanopharm appoints Mark Clement as Chairman of the Board

Adherium announces management changes

Smartinhaler developer Adherium Limited has announced that Thomas Lynch has been appointed the company's new Chairman and that Doug Wilson will step down from the board to take on the role of Medical Director on a part time basis. Lynch recently retired from his role as Chair of ICON after serving on that company's board for over 20 years. He currently serves as … [Read more...] about Adherium announces management changes

Spyryx Biosciences appoints Alistair Wheeler as Chief Medical Officer

Spyryx Biosciences, which is developing an inhaled peptide for the treatment of cystic fibrosis and other respiratory diseases, has announced the appointment of former Sunovion Head of Clinical Research Alistair Wheeler as Chief Medical Officer, a newly created position. Spyryx's SPX-101 is currently in Phase 1 development for the treatment of cystic fibrosis. … [Read more...] about Spyryx Biosciences appoints Alistair Wheeler as Chief Medical Officer

Anna Slater joins PrEP Biopharm as Head of CMC

Johnson & Johnson spinout PrEP Biopharm has announced that former GSK Global Head of Analytical Technologies Anna Slater has joined the company as Head of Chemistry, Manufacturing and Controls. At GSK, Slater had been a Senior Director in the global Inhaled Product & Device Technology Leadership Team, responsible for CMC development of inhaled and nasal products and … [Read more...] about Anna Slater joins PrEP Biopharm as Head of CMC

Hovione opens office in Japan

Spray-drying and DPI specialist Hovione announced the opening a new sales and customer support office in Osaka, Japan, saying that "The new office underlines the importance of Japan for Hovione's business activities. Japan is a strategic market for Hovione where the company is growing both its off patent API and its contract manufacturing businesses. The new office … [Read more...] about Hovione opens office in Japan

MVIC appoints Lars Asking as VP

The Medicon Valley Inhalation Consortium (MVIC) has announced the appointment of Lars Asking as VP as of May 1, 2016. Asking was most recently Principle Scientist at Novo Nordisk and previously developed inhaled products at LAB Pharma and AstraZeneca. MVIC is comprised of 24 member companies with expertise in various areas of inhaled product development. In … [Read more...] about MVIC appoints Lars Asking as VP

InCarda Therapeutics hires Luiz Belardinelli as CMO

InCarda Therapeutics, which is developing an inhaled treatment for paroxysmal atrial fibrillation, has appointed former Gilead Senior VP for Cardiovascular Therapeutics Luiz Belardinelli as Chief Medical Officer, the company said. Belardinelli will continue as a Senior Advisor for Gilead while working for InCarda half time. In April 2015, InCarda announced that … [Read more...] about InCarda Therapeutics hires Luiz Belardinelli as CMO

MannKind announces 4th quarter results, management changes

According to MannKind Corporation, the company's net loss for 2015 was $368.4 million, and its cash and cash equivalents as of the end of 2015 totaled $59.1 million. The company also said that it has hired former Amgen VP, Global Commercial Lead Michael E. Castagna as its Chief Commercial Officer, effective immediately, and announced the resignation of Chief Operating … [Read more...] about MannKind announces 4th quarter results, management changes

Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM

Powder testing specialist Freeman Technology has announced that Managing Director Tim Freeman has received the Richard S. Ladd Standards Development Award from the ASTM for development of ASTM Standard Designation D7891 “Standard Test Method for Shear Testing of Powders using the Freeman Technology FT4 Powder Rheometer Shear Cell.” Freeman's FT4 powder rheometer is … [Read more...] about Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM

MannKind founder Alfred Mann has died at age 90

MannKind Corporation has announced the death of founder and Chairman Emeritus Alfred Mann at age 90, one week after he stepped down as Chairman of the Board. Mann served as CEO from November 2003 until January 2015 and as Chairman of the Board of MannKind from 2001 until last week. According to the company, Mann's death will have no effect on business activities or … [Read more...] about MannKind founder Alfred Mann has died at age 90

  • « Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Interim pages omitted …
  • Page 39
  • Next Page »

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Merxin We Make Inhalers banner
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews